Thyrocare Technologies has informed that the Board of Directors (Board) of Thyrocare Technologies, upon the recommendation of the Nomination and Remuneration Committee (NRC), has approved the appointment of Dr. Ramesh Kinha as Chief Operating Officer of the Company, categorised as Senior Management Personnel, with effect from December 18, 2025. The aforesaid appointment was approved by the Board by way of a resolution passed by circulation on December 18, 2025 at 10:35 AM (IST). In compliance with Regulation 30 of the SEBI LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, the requisite disclosure is enclosed as Annexure - 1. The aforesaid disclosures are also being made available on the website of the Company at https://investor.thyrocare.com/announcements/.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: